360 related articles for article (PubMed ID: 27532807)
1. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
[TBL] [Abstract][Full Text] [Related]
3. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
[TBL] [Abstract][Full Text] [Related]
4. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.
Ko JH; Seok H; Cho SY; Ha YE; Baek JY; Kim SH; Kim YJ; Park JK; Chung CR; Kang ES; Cho D; Müller MA; Drosten C; Kang CI; Chung DR; Song JH; Peck KR
Antivir Ther; 2018; 23(7):617-622. PubMed ID: 29923831
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia.
Kasem S; Qasim I; Al-Hufofi A; Hashim O; Alkarar A; Abu-Obeida A; Gaafer A; Elfadil A; Zaki A; Al-Romaihi A; Babekr N; El-Harby N; Hussien R; Al-Sahaf A; Al-Doweriej A; Bayoumi F; Poon LLM; Chu DKW; Peiris M; Perera RAPM
J Infect Public Health; 2018; 11(3):331-338. PubMed ID: 28993171
[TBL] [Abstract][Full Text] [Related]
6. Antibody Response and Disease Severity in Healthcare Worker MERS Survivors.
Alshukairi AN; Khalid I; Ahmed WA; Dada AM; Bayumi DT; Malic LS; Althawadi S; Ignacio K; Alsalmi HS; Al-Abdely HM; Wali GY; Qushmaq IA; Alraddadi BM; Perlman S
Emerg Infect Dis; 2016 Jun; 22(6):1113-5. PubMed ID: 27192543
[TBL] [Abstract][Full Text] [Related]
7. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
[TBL] [Abstract][Full Text] [Related]
8. Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai.
Lau SKP; Li KSM; Luk HKH; He Z; Teng JLL; Yuen KY; Wernery U; Woo PCY
mSphere; 2020 Jan; 5(1):. PubMed ID: 31969478
[TBL] [Abstract][Full Text] [Related]
9. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.
Müller MA; Meyer B; Corman VM; Al-Masri M; Turkestani A; Ritz D; Sieberg A; Aldabbagh S; Bosch BJ; Lattwein E; Alhakeem RF; Assiri AM; Albarrak AM; Al-Shangiti AM; Al-Tawfiq JA; Wikramaratna P; Alrabeeah AA; Drosten C; Memish ZA
Lancet Infect Dis; 2015 May; 15(5):559-64. PubMed ID: 25863564
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians.
Arabi YM; Al-Enezi F; Longuere KS; Balkhy HH; Al-Sultan M; Al-Omari A; Al-Hameed FM; Carson G; Shindo N; Fowler R
BMC Anesthesiol; 2016 Jul; 16(1):36. PubMed ID: 27405596
[TBL] [Abstract][Full Text] [Related]
11. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
Houser KV; Broadbent AJ; Gretebeck L; Vogel L; Lamirande EW; Sutton T; Bock KW; Minai M; Orandle M; Moore IN; Subbarao K
PLoS Pathog; 2017 Aug; 13(8):e1006565. PubMed ID: 28817732
[TBL] [Abstract][Full Text] [Related]
12. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.
Wang W; Wang H; Deng Y; Song T; Lan J; Wu G; Ke C; Tan W
Emerg Microbes Infect; 2016 Nov; 5(11):e113. PubMed ID: 27826140
[TBL] [Abstract][Full Text] [Related]
13. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
[TBL] [Abstract][Full Text] [Related]
14. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
Okba NMA; Raj VS; Widjaja I; GeurtsvanKessel CH; de Bruin E; Chandler FD; Park WB; Kim NJ; Farag EABA; Al-Hajri M; Bosch BJ; Oh MD; Koopmans MPG; Reusken CBEM; Haagmans BL
Emerg Infect Dis; 2019 Oct; 25(10):1868-1877. PubMed ID: 31423970
[TBL] [Abstract][Full Text] [Related]
15. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
[TBL] [Abstract][Full Text] [Related]
16. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012.
Memish ZA; Alsahly A; Masri MA; Heil GL; Anderson BD; Peiris M; Khan SU; Gray GC
Influenza Other Respir Viruses; 2015 Mar; 9(2):64-7. PubMed ID: 25470665
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016.
Degnah AA; Al-Amri SS; Hassan AM; Almasoud AS; Mousa M; Almahboub SA; Alhabbab RY; Mirza AA; Hindawi SI; Alharbi NK; Azhar EI; Hashem AM
J Infect Public Health; 2020 May; 13(5):697-703. PubMed ID: 32005618
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.
Harcourt JL; Rudoler N; Tamin A; Leshem E; Rasis M; Giladi M; Haynes LM
Zoonoses Public Health; 2018 Sep; 65(6):749-754. PubMed ID: 29855166
[TBL] [Abstract][Full Text] [Related]
19. Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia.
Al-Abdely HM; Midgley CM; Alkhamis AM; Abedi GR; Lu X; Binder AM; Alanazi KH; Tamin A; Banjar WM; Lester S; Abdalla O; Dahl RM; Mohammed M; Trivedi S; Algarni HS; Sakthivel SK; Algwizani A; Bafaqeeh F; Alzahrani A; Alsharef AA; Alhakeem RF; Jokhdar HAA; Ghazal SS; Thornburg NJ; Erdman DD; Assiri AM; Watson JT; Gerber SI
Emerg Infect Dis; 2019 Apr; 25(4):753-766. PubMed ID: 30882305
[TBL] [Abstract][Full Text] [Related]
20. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol.
Arabi Y; Balkhy H; Hajeer AH; Bouchama A; Hayden FG; Al-Omari A; Al-Hameed FM; Taha Y; Shindo N; Whitehead J; Merson L; AlJohani S; Al-Khairy K; Carson G; Luke TC; Hensley L; Al-Dawood A; Al-Qahtani S; Modjarrad K; Sadat M; Rohde G; Leport C; Fowler R
Springerplus; 2015; 4():709. PubMed ID: 26618098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
